drugset / Trial / NCT04451174
Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia
RandomizedParallel-groupSingle-blindTreatment
Summary
Steroids has shown benefits in COVID19 patients in observational studies. We hypothesized that early use of corticosteroids, low dose, in mild disease, can decrease progression to respiratory failure and death.
Timeline
- Start
- 2020-06-23
- Primary completion
- 2021-01-30
- Completion
- 2021-01-30
Outcome
Outcome not reported
Stopped: “Corticosteroid use approval”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | 20 mg | — |